文献速递产科母胎医学

球囊阻断在加州植入性胎盘登记研究中的结局

Outcomes of balloon occlusion in the University of California Morbidly Adherent Placenta Registry.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-11-09

该回顾性多中心研究纳入了171例接受剖宫产子宫切除术的植入性胎盘谱系疾病患者,比较了术前主动脉或髂动脉球囊阻断、术中髂内动脉结扎与无辅助措施三组的结局。结果显示,球囊阻断组的估计失血量、输血需求、ICU入住率及不良事件率均显著低于其他两组。

要点

  • 球囊阻断组估计失血量较无辅助组降低30.9%,较髂内动脉结扎组降低54.2%。
  • 球囊阻断组输血需求较无辅助组降低76.8%,较髂内动脉结扎组降低90.5%。
  • 球囊阻断组ICU入住率为0%,显著低于无辅助组的15.2%和髂内动脉结扎组的77.8%。

核心结论

  • 主动脉或髂动脉球囊阻断与更低的估计失血量、输血需求、ICU入住率及不良事件率相关。

研究设计与样本

  • 2014年5月至2018年4月在5家机构开展的回顾性研究,纳入171例接受剖宫产子宫切除术的植入性胎盘谱系疾病患者。

主要发现

  • 与无辅助措施组相比,球囊阻断组估计失血量降低30.9%(P<.001),输血需求降低76.8%(P<.001)。
  • 与无辅助措施组相比,球囊阻断组ICU入住率0% vs 15.2%(P<.001),ICU停留时间0.0 vs 3.1天(P<.001)。
  • 与髂内动脉结扎组相比,球囊阻断组估计失血量降低54.2%(P<.01),输血需求降低90.5%(P<.001)。
  • 与髂内动脉结扎组相比,球囊阻断组手术时间降低40.0%(P<.01),ICU入住率0% vs 77.8%(P<.001),ICU停留时间0.0 vs 1.4天(P<.001)。
  • 与髂内动脉结扎组相比,球囊阻断组不良事件发生率3.6% vs 44.4%(P<.01)。

临床怎么用

  • 对于植入性胎盘谱系疾病行剖宫产子宫切除术的患者,可考虑术前放置主动脉或髂动脉球囊阻断以减少失血和输血。
  • 球囊阻断可能降低ICU入住率和不良事件率,但需结合机构资源和团队经验选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Morbidly adherent placenta, also known as placenta accreta spectrum, is associated with severe maternal morbidity and mortality. Multiple adjunctive procedures have been proposed to improve outcomes, and at many institutions, interventional radiologists will play a role in assisting obstetricians in these cases. OBJECTIVE: The objective of the study was to evaluate the outcomes of women with morbidly adherent placenta who underwent cesarean hysterectomy with aortic balloon occlusion or internal iliac artery balloon occlusion catheters, compared with cesarean hysterectomy with surgical ligation of the iliac arteries, or cesarean hysterectomy without adjunctive procedures. STUDY DESIGN: A retrospective review of women with morbidly adherent placenta treated with cesarean hysterectomy was performed at 5 institutions from May 2014 to April 2018. The balloon occlusion group had either prophylactic aortic or iliac balloons placed prior to cesarean hysterectomy. Comparison groups included those who underwent internal iliac artery ligation prior to hysterectomy or a control group if they underwent cesarean hysterectomy without adjuvant procedures. Evaluated outcomes include estimated blood loss, transfusion requirements, intensive care unit admission, and adverse event rates. RESULTS: There were 171 women with morbidly adherent placenta included in the study. Twenty-eight had balloon placement prior to cesarean hysterectomy, 18 had intraoperative internal iliac artery ligation, and there were 125 control women who underwent cesarean hysterectomy without any adjunctive procedures. Compared with the women who underwent cesarean hysterectomy without adjunctive procedures, women who underwent aortic or iliac artery balloon occlusion prior to hysterectomy had significantly lower estimated blood loss (30.9% decrease, P < .001), transfusion requirements (76.8% decrease, P < .001), intensive care unit admission rates (0% vs 15.2%, P < .001), and intensive care unit stay lengths (0.0 vs 3.1 days, P < .001). Compared with women who underwent surgical ligation of the internal iliac arteries prior to hysterectomy, women who underwent aortic or iliac artery balloon occlusion prior to cesarean hysterectomy had lower estimated blood loss (54.2% decrease, P < .01), transfusion requirements (90.5% decrease, P < .001), operating room times (40.0% decrease, P < .01), intensive care unit admissions rates (0% vs 77.8%, P < .001), intensive care unit stay lengths (0.0 vs 1.4 days, P < .001), and adverse events (3.6% vs 44.4%, P < .01). CONCLUSION: Aortic and iliac artery balloon occlusion are associated with lower estimated blood loss, transfusion requirements, intensive care unit admission rates, and adverse event rates compared with women who underwent internal iliac artery ligation prior to cesarean hysterectomy or women who had no adjunctive interventions prior to cesarean hysterectomy for morbidly adherent placenta.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lee AY, Ballah D, Moreno I, et al. Outcomes of balloon occlusion in the University of California Morbidly Adherent Placenta Registry. Am J Obstet Gynecol MFM. 2019. PMID: 33345981. doi:10.1016/j.ajogmf.2019.100065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。